Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Antiaging Gene SIRT1 Found to Suppress Alzheimer's Protein

By LabMedica International staff writers
Posted on 20 Aug 2010
SIRT1, a gene associated with antiaging, has been found to suppress a protein associated with Alzheimer's disease (AD), according to recent findings.

Researchers from the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) found that SIRT1 appears to prevent production of damaging A-beta peptides that make up amyloid plaques that form in the brain of people with AD. More...
They also demonstrated that learning and memory improved when SIRT1--protein was overproduced in the brain of mice engineered to develop Alzheimer's.

SIRT1 is a "rescue gene” that repairs the damage done by free radicals and prevents cells from dying prematurely. The gene also causes mitochondria to generate energy at higher levels that are typically associated with younger cells.

Dr. Susanne Sorensen, head of research at the UK Alzheimer's Society (London), commented, "SIRT1 certainly appears to be everybody's favorite gene at the moment. Activated by calorie restriction and a compound found in red wine, research has shown that it can help animals to live longer. Now scientists may have linked it to the control of a key protein associated with the development of Alzheimer's-type dementia. Much more research is now needed before we can find out if drugs that activate SIRT1 could be used to fight dementia.”

The study's findings were published July 23, 2010, in the journal Cell.

Related Links:
Massachusetts Institute of Technology
UK Alzheimer's Society





Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.